Skip to main content
Premium Trial:

Request an Annual Quote

Immusol Signs Up for Celera Discovery System

SAN FRANCISCO, Nov. 8 – Biopharmaceutical company Immusol signed a multi-year subscription to Celera Genomics’ Discovery System, the companies announced Thursday.

Financial terms of the agreement between Immusol, based in San Diego, Calif., and Rockville, Md.-based Celera, were not disclosed.

“The combination of the Celera system with our Inverse Genomics platform will greatly expand our capacity to identify and develop therapeutic targets and compounds both for partnerships and internal screening efforts,” Jack Barber, vice president of research and development at Immusol, said in a statement.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.